The first application of our innovative technology will be to create Cytophages that will reduce and ultimately replace the use of antibiotics for illness prevention and growth enhancement in livestock, starting with poultry.
We’re developing a poultry feed additive that prevents the most common bacterial infections in chickens — Campylobacter, Salmonella and E. coli. This product will replace antibiotics commonly used in chicken barns, resulting in antibiotic-free chickens — a regulatory imperative and a commercial benefit in today’s marketplace.
At the same time, we’ll look to develop products for all livestock including swine, cattle, and fish.
And this is just the beginning. We have the technology to cure all bacterial infections that affect human health, animal health and food safety, especially antimicrobial resistant infections.
In development is a spray to be used in hospitals to tackle MRSA contaminations.